News
Investing.com -- Sarepta Therapeutics shares plunged premarket on Friday after the company disclosed another patient death ...
(Reuters) -Shares of Sarepta Therapeutics declined 16.5% in premarket trading on Friday after a Bloomberg report that a trial patient who received an experimental gene therapy has died from liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results